Oral administration of the methanol extraction residue of BCG (MER/BCG): A phase I study in non-oat cell lung cancer patients
- 1 January 1983
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 5 (4) , 329-334
- https://doi.org/10.1016/0192-0561(83)90036-x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Treatment of disseminated malignant melanoma with high-dose oral BCGCancer, 1981
- Immune investigations and therapy in patients with advanced lung cancerCancer Immunology, Immunotherapy, 1980
- The effect of methanol extraction residue of BCG on the cellular immune response in patients with malignant melanomaMedical and Pediatric Oncology, 1979
- Multiple Lymphocyte Transformation Tests by Phytohemagglutinin in Healthy IndividualsActa Haematologica, 1978
- A preliminary study of intravenous methanol extraction residue of BCG in treatment of advanced cancerBritish Journal of Cancer, 1977
- The use of oral BCG in the treatment of metastatic malignant melanomaMedical and Pediatric Oncology, 1976
- A preliminary report on the effects of methanol extraction residue of BCG (MER) on cancer patientsBritish Journal of Cancer, 1975
- THE ORIGIN OF THE IMMUNOGLOBULINS IN INTESTINAL LYMPH OF SHEEPImmunology & Cell Biology, 1975